197 related articles for article (PubMed ID: 29775761)
41. The effect of Irisin on bone cells in vivo and in vitro.
Buccoliero C; Oranger A; Colaianni G; Pignataro P; Zerlotin R; Lovero R; Errede M; Grano M
Biochem Soc Trans; 2021 Feb; 49(1):477-484. PubMed ID: 33449117
[TBL] [Abstract][Full Text] [Related]
42. Potential of l-thyroxine to differentiate osteoblast-like cells via Angiopoietin1.
Park SH; Lee J; Kang MA; Moon YJ; Wang SI; Kim KM; Park BH; Jang KY; Kim JR
Biochem Biophys Res Commun; 2016 Sep; 478(3):1409-15. PubMed ID: 27569283
[TBL] [Abstract][Full Text] [Related]
43. Requirement of TGFβ Signaling for Effect of Fluoride on Osteoblastic Differentiation.
Zhang J; Jiang N; Yu H; Yu X; Guo F; Zhao Z; Xu H
Biol Trace Elem Res; 2019 Feb; 187(2):492-498. PubMed ID: 29770951
[TBL] [Abstract][Full Text] [Related]
44. Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes.
Gao S; Li F; Li H; Huang Y; Liu Y; Chen Y
PLoS One; 2016; 11(1):e0147480. PubMed ID: 26799325
[TBL] [Abstract][Full Text] [Related]
45. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the metabolic effects of irisin on skeletal muscle in vitro.
Vaughan RA; Gannon NP; Barberena MA; Garcia-Smith R; Bisoffi M; Mermier CM; Conn CA; Trujillo KA
Diabetes Obes Metab; 2014 Aug; 16(8):711-8. PubMed ID: 24476050
[TBL] [Abstract][Full Text] [Related]
47. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
48. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
Merciris D; Marty C; Collet C; de Vernejoul MC; Geoffroy V
Am J Pathol; 2007 May; 170(5):1676-85. PubMed ID: 17456773
[TBL] [Abstract][Full Text] [Related]
50. Glutamate Receptor Agonists and Glutamate Transporter Antagonists Regulate Differentiation of Osteoblast Lineage Cells.
Xie W; Dolder S; Siegrist M; Wetterwald A; Hofstetter W
Calcif Tissue Int; 2016 Aug; 99(2):142-54. PubMed ID: 27016923
[TBL] [Abstract][Full Text] [Related]
51. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
52. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
[TBL] [Abstract][Full Text] [Related]
53. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H
J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936
[TBL] [Abstract][Full Text] [Related]
54. Isolation and characterization of a novel peptide, osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation.
Fukushima N; Hiraoka K; Shirachi I; Kojima M; Nagata K
Biochem Biophys Res Commun; 2010 Sep; 400(1):157-63. PubMed ID: 20709021
[TBL] [Abstract][Full Text] [Related]
55. Cyclic stretch enhances bone morphogenetic protein-2-induced osteoblastic differentiation through the inhibition of Hey1.
Zeng Z; Yin X; Zhang X; Jing D; Feng X
Int J Mol Med; 2015 Nov; 36(5):1273-81. PubMed ID: 26647760
[TBL] [Abstract][Full Text] [Related]
56. Osterix is required for Sonic hedgehog-induced osteoblastic MC3T3-E1 cell differentiation.
Tian Y; Xu Y; Fu Q; Dong Y
Cell Biochem Biophys; 2012 Dec; 64(3):169-76. PubMed ID: 22648388
[TBL] [Abstract][Full Text] [Related]
57. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
58. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
59. Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission.
Colucci S; Colaianni G; Brunetti G; Ferranti F; Mascetti G; Mori G; Grano M
FASEB J; 2020 Aug; 34(8):10096-10106. PubMed ID: 32539174
[TBL] [Abstract][Full Text] [Related]
60. Irisin enhances osteoblast differentiation in vitro.
Colaianni G; Cuscito C; Mongelli T; Oranger A; Mori G; Brunetti G; Colucci S; Cinti S; Grano M
Int J Endocrinol; 2014; 2014():902186. PubMed ID: 24723951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
